Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c187
Identifier NCT05722353
Trial Title IBD Disease Course of Infliximab-naive IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions OTHER: Biocollection
Participant Information
Sponsor Assistance Publique - Hôpital de Paris
City Paris
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2023-02-13
Primary Completion Date 2025-11-25
Completion Date 2025-11-25